You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses

Article metrics

Article menu

Download PDFPDF

XML
Mental health
Research
Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses

 

Online download statistics by month:

Online download statistics by month: March 2019 to June 2025

AbstractFullPdf
Mar 201917717717
Apr 2019404394182
May 2019479474146
Jun 2019310308119
Jul 2019209208142
Aug 2019219218225
Oct 2019251244358
Nov 2019215215307
Dec 2019236236322
Jan 2020228227395
Feb 2020205202413
Mar 2020232232571
May 2020157157432
Jun 2020112110369
Jul 20209788304
Aug 2020116106317
Sep 2020113108333
Oct 2020161157494
Nov 2020228213651
Dec 2020129122497
Jan 2021138128656
Feb 2021118103541
Mar 2021184162679
Apr 2021199174768
May 2021187177552
Jun 20218470389
Jul 20217466314
Aug 2021106105298
Sep 202110291336
Oct 202110491368
Nov 20219885183
Dec 20218373323
Jan 20229575324
Feb 20229388303
Mar 2022127104452
Apr 2022143114502
May 2022151128460
Jun 20228673269
Jul 20226655158
Aug 20227545174
Sep 20224436349
Oct 20226651204
Nov 202211898253
Dec 20229070206
Jan 2023128103197
Feb 2023118107149
Mar 2023131113152
Apr 2023129106212
May 20238871193
Jun 202310188127
Jul 20238172121
Aug 2023735585
Sep 20235951172
Oct 202311692147
Nov 202315183189
Dec 202312063106
Jan 2024646219
Feb 2024777858
Mar 2024175148290
Apr 2024192144264
May 20249268145
Jun 202410267108
Jul 2024103612675
Aug 2024724379
Sep 20245328130
Oct 20249470155
Nov 20249980113
Dec 20244331122
Jan 20259274142
Feb 20251069879
Mar 20256143102
Apr 20256240152
May 2025574488
Jun 2025151115
Total9763865222241